Tuberculosis (TB) is a leading cause of death from infectious disease and is very difficult to control due to multiple drug resistances. Rapid identification of TB and its drug resistance profile is critical for management and surveillance of disease. Current testing options are insufficient due to the length of time for culture-based results or limited drug resistance results from molecular tests.

The Genoscreen Deeplex Myc-TB next-generation sequencing (NGS) assay detects more than 100 mycobacterium species and provides an extensive drug resistance profile for 15 antibiotics commonly used for TB. Results are available in less than 48 hours directly from a sputum sample or cultured isolate. TB detection with drug resistance in an actionable timeframe is a leap forward in managing and monitoring tuberculosis.

At the end of this webinar, attendees will be able to:

• Understand the current tuberculosis landscape and global impact of drug resistance on TB management
• Describe how next-generation sequencing is used to identify, detect and monitor TB drug resistance
• Explain how the Deeplex Myc-TB assay fits into a laboratory workflow

Darcy Whitlock Senior Staff Product Manager, Illumina Inc.

Darcy Whitlock is committed to expanding the use of genomics in infectious disease and microbiology. Darcy is a Senior Global Product Manager at Illumina and is responsible for the COVID-19 portfolio and growth of the infectious disease portfolio. After completing her Masters in molecular biology, Darcy worked at a fertility clinic performing preimplantation genetic testing of embryos. Moving into clinical diagnostic research and development, Darcy focused on the development of clinical diagnostics for infectious and autoimmune gastrointestinal diseases. She has extensive experience in respiratory disease diagnosis, from both a research and marketing perspective, including the earliest bedside molecular tests for respiratory disease cleared by the US FDA. Darcy joined Illumina in 2021, and is based out of Fort Collins, Colorado.